A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19
← catalyst calendarSponsored by Shionogi (industry) · 4507.T — their whole pipeline →. With National Institute of Allergy and Infectious Diseases (NIAID).
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
2,093actual
Sites
196
Countries
Argentina, Brazil, Colombia +14
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-20
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-08-03 | actual | When the study began enrolling |
| Primary completion | 2024-01-07 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2024-05-24 | actual | The whole study's end, after follow-up |
| First posted | 2022-03-31 | actual | When this record first appeared on the registry |
| Results posted | 2026-08-20 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- SARS-CoV-2 Infection
Interventions
- Drug: S-217622
- Drug: Placebo
Primary outcome
what the primary-completion date above is the date OFTime to Sustained Symptom Resolution
measured Up to Day 29
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2023-10-25 · 924 KB · Prot_001.pdf
Statistical Analysis Planposted 2024-03-13 · 1.4 MB · SAP_002.pdf
Informed Consent Formposted 2023-03-10 · 443 KB · ICF_000.pdf
Publications
- PMID 39960062 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · 4507.T's whole pipeline · Catalyst calendar · Every registered study · What changed